INTRAOPERATIVE SPILLAGE OF FAVORABLE HISTOLOGY WILMS TUMOR CELLS: INFLUENCE OF IRRADIATION AND CHEMOTHERAPY REGIMENS ON ABDOMINAL RECURRENCE. A REPORT FROM THE NATIONAL WILMS TUMOR STUDY GROUP

被引:29
作者
Kalapurakal, John A. [1 ]
Li, Sierra M. [2 ]
Breslow, Norman E. [2 ]
Beckwith, J. Bruce
Ritchey, Michael L. [3 ]
Shamberger, Robert C. [4 ]
Haase, Gerald M. [5 ]
Thomas, Patrick R. M. [6 ]
Grundy, Paul [7 ]
Green, Daniel M. [8 ]
D'Angio, Giulio J. [9 ]
机构
[1] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Pediat Urol Associates, Phoenix, AZ USA
[4] Boston Childrens Hosp, Boston, MA USA
[5] Denver Childrens Hosp, Denver, CO USA
[6] Hershey Med Ctr, Hershey, PA USA
[7] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[8] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[9] Univ Penn, Philadelphia, PA 19104 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 76卷 / 01期
关键词
Wilms tumor; Radiation therapy; Tumor spillage; Local recurrence; Survival; RADIATION-THERAPY; ACTINOMYCIN-D; 2ND; SINGLE;
D O I
10.1016/j.ijrobp.2009.01.046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We undertook this study to determine (1) the frequency with which spilled tumor cells of favorable histology produced intra-abdominal disease in patients treated with differing chemotherapy regimens and abdominal radiation therapy (RT) and (2) the patterns of relapse and outcomes in such patients. Methods and Materials: The influence of RT dose (0, 10, and 20 Gy), RT fields (flank, whole abdomen), and chemotherapy with cl actinomycin and vincristine (2 drugs) vs. added doxorubicin (three drugs) on intra-abdominal tumor recurrence rates was analyzed by logistic regression in 450 patients. Each patient was considered at risk for two types of failure: flank and subdiaphragmatic beyond-flank recurrence, with the correlation between the two outcomes accounted for in the analyses. Results: The crude odds ratio for the risk of recurrence relative to no RT was 0.35 (0.15-0.78) for 10Gy and 0.08 (0.01-0.58) for 20Gy. The odds ratio for the risk of recurrence for doxorubicin to two drugs after adjusting for RT was not significant. For Stage II patients (NWTS-4), the 8-year event rates with and without spillage, respectively, were 79% and 87% for relapse-free survival (p = 0.07) and 90% and 95% for overall survival (p = 0.04). Conclusions: Irradiation (10 Gy or 20 Gy) reduced abdominal tumor recurrence rates after tumor spillage. Tumor spillage in Stage II patients reduced relapse-free survival and overall survival, but only the latter was of statistical significance. These data provide a basis for assessing the risks vs. benefits when considering treatment for children with favorable histology Wilms tumor and surgical spillage. (C) 2010 Elsevier Inc.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 28 条
[1]   2ND MALIGNANT NEOPLASMS FOLLOWING TREATMENT FOR WILMS-TUMOR - A REPORT FROM THE NATIONAL WILMS-TUMOR STUDY-GROUP [J].
BRESLOW, NE ;
TAKASHIMA, JR ;
WHITTON, JA ;
MOKSNESS, J ;
DANGIO, GJ ;
GREEN, DM .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1851-1859
[2]   Radiation therapy for favorable histology Wilms tumor: Prevention of flank recurrence did not improve survival on national wilms tumor studies 3 and 4 [J].
Breslow, Norman E. ;
Beckwith, J. Bruce ;
Haase, Gerald M. ;
Kalapurakal, John A. ;
Ritchey, Michael L. ;
Shamberger, Robert C. ;
Thomas, Patrick R. M. ;
D'Angio, Giulio J. ;
Green, Daniel M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01) :203-209
[3]   Pre- or postoperative therapy for Wilms' tumor? [J].
D'Angio, Giulio J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) :4055-4057
[4]   Pre- or post-operative treatment for Wilms tumor? Who, what, when, where, how, why - and which [J].
D'Angio, GJ .
MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 41 (06) :545-549
[5]  
DANGIO GJ, 1976, CANCER-AM CANCER SOC, V38, P633, DOI 10.1002/1097-0142(197608)38:2<633::AID-CNCR2820380203>3.0.CO
[6]  
2-S
[7]  
DANGIO GJ, 1981, CANCER-AM CANCER SOC, V47, P2302, DOI 10.1002/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO
[8]  
2-K
[9]  
DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO
[10]  
2-Q